{"profile":{"id":"7e89f88e-d86b-4d4b-851c-b033e106cb8c","slug":"neotx-ltd-rehovot-87cc","business_name":"NeoTX","website_url":"https://neotx.com","industry":"Medical laboratory","city":"Rehovot","services":[{"category":"service","price_range":null,"service_area":null,"service_name":"Tumor Targeted Superantigen (TTS) Platform","target_customer":"Pharmaceutical companies and research institutions","factual_description":"A technology that coats tumors with a bacterial derivative to elicit an antibacterial immune response, potentially effective in patients unresponsive to current immunotherapies.","related_capabilities":[]},{"category":"product","price_range":null,"service_area":null,"service_name":"Naptumomab Estafenatox (NAP)","target_customer":"Pharmaceutical companies and research institutions","factual_description":"NeoTX's lead TTS candidate, currently in Phase 1b clinical trials for advanced and metastatic solid tumors, in collaboration with AstraZeneca.","related_capabilities":[]},{"category":"service","price_range":null,"service_area":null,"service_name":"Clinical Trial Participation","target_customer":"Patients with advanced or metastatic cancers","factual_description":"Conducting Phase 1b clinical trials for NAP in combination with checkpoint inhibitors for patients with recurrent solid tumors.","related_capabilities":[]}],"schema_json":{"@graph":[{"@id":"https://www.vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd#business","geo":{"@type":"GeoCoordinates","latitude":31.9114273,"longitude":34.805187499999995},"url":"https://neotx.com","name":"NeoTX","@type":"LocalBusiness","image":"https://neotx.com/wp-content/uploads/2020/03/cropped-favicon-180x180.png","hasMap":"https://www.google.com/maps/place/?cid=17992167132276308764","sameAs":["https://neotx.com/neotx-2/","https://www.google.com/maps/place/?cid=17992167132276308764"],"address":{"@type":"PostalAddress","addressCountry":"IL","addressLocality":"Rehovot"},"audience":[{"@type":"Audience","audienceType":"Pharmaceutical companies seeking oncology partnerships"},{"@type":"Audience","audienceType":"Oncology researchers developing new therapies"},{"@type":"Audience","audienceType":"Patients with advanced solid tumors"}],"speakable":{"@type":"SpeakableSpecification","cssSelector":["[data-ai-block=\"summary\"]","[data-ai-block=\"about\"]","[data-ai-block=\"micro-faq\"]","[data-ai-block=\"faq\"]"]},"telephone":"+972-3-912-5853","areaServed":[{"name":"Rehovot","@type":"City"}],"identifier":[{"@type":"PropertyValue","value":"ChIJVVOv4uS2AhURHLvJIq4Esfk","propertyID":"Google Place ID"},{"@type":"PropertyValue","value":"vizoryo:profile:7e89f88e-d86b-4d4b-851c-b033e106cb8c","propertyID":"VizoryoProfileID"}],"knowsAbout":["Quantum mechanics in drug discovery"],"description":"NeoTX, a cancer therapeutics company based in Rehovot, Israel, specializes in quantum mechanics applications for drug discovery. The company develops treatments such as the Tumor Targeted Superantigen (TTS) Platform and Naptumomab Estafenatox (NAP). NeoTX also facilitates clinical trial participation for patients with advanced solid tumors.","dateModified":"2026-04-13","datePublished":"2026-04-13","additionalType":"Medical Laboratory - Cancer Therapeutics","mainEntityOfPage":"https://www.vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd","openingHoursSpecification":[{"@type":"OpeningHoursSpecification","opens":"09:00","closes":"18:00","dayOfWeek":"Monday"},{"@type":"OpeningHoursSpecification","opens":"09:00","closes":"18:00","dayOfWeek":"Tuesday"},{"@type":"OpeningHoursSpecification","opens":"09:00","closes":"18:00","dayOfWeek":"Wednesday"},{"@type":"OpeningHoursSpecification","opens":"09:00","closes":"18:00","dayOfWeek":"Thursday"},{"@type":"OpeningHoursSpecification","opens":"09:00","closes":"18:00","dayOfWeek":"Sunday"}],"additionalProperty":[{"@type":"PropertyValue","name":"dataConfidence","description":"Cross-source data consistency score (0–1). Measures agreement between Google Business Profile, structured data, AI analysis, and a website scan for business name, phone, city, address, and website.","value":0.9},{"@type":"PropertyValue","name":"sourcesCrossChecked","description":"Count of public sources this record was read from and compared across for the core business details (name, phone, address, city, category, website). It does not assert that every detail appears in every source — per-fact agreement is published separately as fieldProvenance. The sources are not necessarily independent of one another. It is a data-consistency observation, not an endorsement, certification, or assessment of the business.","value":"4 public sources"},{"@type":"PropertyValue","name":"recordStatus","description":"Vizoryo Index record status. owner_claimed = the business owner claimed this record on a paid plan and maintains it; this is not an endorsement or an independent check by Vizoryo. community_confirmed = a signed-in person confirmed the details look right; not necessarily the owner. owner_submitted = the details were typed in by someone who says they run the business; nobody has checked them and no audit ran. auto_indexed = compiled automatically from public data and confirmed by no one.","value":"auto_indexed"},{"@type":"PropertyValue","name":"fieldProvenance","description":"Per-field provenance: how many of the public sources read for this record carried each key business fact, and how strongly they agree. Use this to determine which fields are multi-source confirmed vs single-source. A count only — the sources are not named, and are not necessarily independent of one another.","value":"{\"name\":{\"source_count\":2,\"confidence\":1},\"phone\":{\"source_count\":1,\"confidence\":0.9},\"address\":{\"source_count\":1,\"confidence\":0.9},\"category\":{\"source_count\":1,\"confidence\":0.6},\"website\":{\"source_count\":2,\"confidence\":1},\"hours\":{\"source_count\":1,\"confidence\":0.9}}"}]},{"@id":"https://www.vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd#service-0","name":"Tumor Targeted Superantigen (TTS) Platform","@type":"Service","category":"service","provider":{"@id":"https://www.vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd#business"},"areaServed":{"name":"Rehovot","@type":"City"},"description":"A technology that coats tumors with a bacterial derivative to elicit an antibacterial immune response, potentially effective in patients unresponsive to current immunotherapies."},{"@id":"https://www.vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd#service-1","name":"Naptumomab Estafenatox (NAP)","@type":"Service","category":"product","provider":{"@id":"https://www.vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd#business"},"areaServed":{"name":"Rehovot","@type":"City"},"description":"NeoTX's lead TTS candidate, currently in Phase 1b clinical trials for advanced and metastatic solid tumors, in collaboration with AstraZeneca."},{"@id":"https://www.vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd#service-2","name":"Clinical Trial Participation","@type":"Service","category":"service","provider":{"@id":"https://www.vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd#business"},"areaServed":{"name":"Rehovot","@type":"City"},"description":"Conducting Phase 1b clinical trials for NAP in combination with checkpoint inhibitors for patients with recurrent solid tumors."},{"@id":"https://www.vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd#faq","name":"FAQ - NeoTX","@type":"FAQPage","mainEntity":[{"name":"What areas does NeoTX serve?","@type":"Question","acceptedAnswer":{"text":"NeoTX serves Worldwide.","@type":"Answer"}},{"name":"What is NeoTX's core technology?","@type":"Question","acceptedAnswer":{"text":"NeoTX's core technology is the Tumor Targeted Superantigen (TTS) platform, which uses a bacterial derivative to stimulate an immune response against cancer cells.","@type":"Answer"}},{"name":"What is Naptumomab Estafenatox (NAP) being developed for?","@type":"Question","acceptedAnswer":{"text":"NAP, NeoTX’s lead TTS candidate, is currently being evaluated in Phase 1b clinical trials for advanced and metastatic solid tumor indications.","@type":"Answer"}},{"name":"Who are the key scientific advisors involved with NeoTX?","@type":"Question","acceptedAnswer":{"text":"NeoTX involves Nobel Prize laureates Prof. Michael Levitt, Prof. Roger Kornberg (Chairman of the Board), and Prof. Arieh Warshel in its research and development.","@type":"Answer"}}]}],"@context":"https://schema.org"},"created_at":"2026-04-13T15:17:25.590474+00:00","updated_at":"2026-07-03T02:31:33.546+00:00","faq":[{"answer":"NeoTX serves Worldwide.","category":"location","question":"What areas does NeoTX serve?"},{"answer":"NeoTX's core technology is the Tumor Targeted Superantigen (TTS) platform, which uses a bacterial derivative to stimulate an immune response against cancer cells.","category":"general","question":"What is NeoTX's core technology?"},{"answer":"NAP, NeoTX’s lead TTS candidate, is currently being evaluated in Phase 1b clinical trials for advanced and metastatic solid tumor indications.","category":"general","question":"What is Naptumomab Estafenatox (NAP) being developed for?"},{"answer":"NeoTX involves Nobel Prize laureates Prof. Michael Levitt, Prof. Roger Kornberg (Chairman of the Board), and Prof. Arieh Warshel in its research and development.","category":"general","question":"Who are the key scientific advisors involved with NeoTX?"}],"country":"Israel","og_image_url":"https://neotx.com/wp-content/uploads/2020/03/cropped-favicon-180x180.png","industry_subtype":null,"profile_tier":"free","short_tagline":null,"primary_category":"Medical Laboratory","schema_type":"LocalBusiness","primary_address":{"city":"Rehovot","region":null,"street":null,"country":"IL","postal_code":null},"geo_coordinates":{"lat":31.9114273,"lng":34.805187499999995},"service_areas":["Rehovot"],"phone":"+972-3-912-5853","hours_by_day":[{"day":"monday","open":"09:00","close":"18:00"},{"day":"tuesday","open":"09:00","close":"18:00"},{"day":"wednesday","open":"09:00","close":"18:00"},{"day":"thursday","open":"09:00","close":"18:00"},{"day":"friday","open":"00:00","close":"00:00","is_closed":true},{"day":"saturday","open":"00:00","close":"00:00","is_closed":true},{"day":"sunday","open":"09:00","close":"18:00"}],"price_range":null,"review_summary":{"sources":[{"count":1,"rating":5,"platform":"google"}],"total_count":1,"distribution":{"1":0,"2":0,"3":0,"4":0,"5":1},"average_rating":5},"certifications":[],"years_in_business":null,"founded_year":null,"specialties":["Quantum mechanics in drug discovery"],"differentiators":[],"social_profiles":[{"url":"https://neotx.com/neotx-2/","platform":"twitter"}],"citations":[],"data_sources":["Website Scan","Social Media Profiles","AI Content Analysis","Google Business Profile"],"languages_supported":["en"],"profile_language":"en","ai_readability_score":39,"claimed_at":null,"index_status":"listed","industry_category":"Medical Laboratory - Cancer Therapeutics","llm_optimized_summary":"NeoTX, a cancer therapeutics company based in Rehovot, Israel, specializes in quantum mechanics applications for drug discovery. The company develops treatments such as the Tumor Targeted Superantigen (TTS) Platform and Naptumomab Estafenatox (NAP). NeoTX also facilitates clinical trial participation for patients with advanced solid tumors.","target_audience":["Pharmaceutical companies seeking oncology partnerships","Oncology researchers developing new therapies","Patients with advanced solid tumors"],"alternative_to":[],"data_trust_signal":"https://neotx.com","category_local":null,"city_local":null,"country_local":null,"is_regulated":false,"parent_profile_id":null,"profile_type":"standalone","branch_address":null,"branch_phone":null,"branch_hours":null,"branch_geo":null,"google_place_id":"ChIJVVOv4uS2AhURHLvJIq4Esfk","ai_mention_count":0,"last_ai_mention_at":null,"logo_url":"https://icons.duckduckgo.com/ip3/neotx.com.ico","url_path":"medical-laboratory/rehovot/neotx-ltd","business_name_en":"NeoTX","data_confidence":0.89675,"ai_mention_score":null,"business_name_native":null,"canonical_domain":null,"social_proof":null,"external_links":{"maps_url":"https://www.google.com/maps/place/?cid=17992167132276308764","twitter_url":"https://neotx.com/neotx-2/"},"amenities":[],"payment_methods":[],"operational_status":"open","is_software_product":false,"field_audit_trail":null,"amenities_typed":null,"industry_canonical":"Medical Laboratory","name_forms":["NeoTX"],"same_as":["https://neotx.com","https://www.google.com/maps/place/?cid=17992167132276308764","https://neotx.com/neotx-2/"],"platform_signals":null,"record_checked_at":"2026-04-13T15:17:25.555+00:00","trust_state":"indexed","record_status":"auto_indexed","profile_completeness":{"filled":11,"total":15,"tier_unlocks":{"statistics":0,"intent_segments":0,"knowsabout_depth":0,"buyer_faq":0}},"freshness_days":108,"confirmation_count":0,"vizoryo_profile_id":"vizoryo:profile:7e89f88e-d86b-4d4b-851c-b033e106cb8c","canonical_summary":"NeoTX, a cancer therapeutics company based in Rehovot, Israel, specializes in quantum mechanics applications for drug discovery. The company develops treatments such as the Tumor Targeted Superantigen (TTS) Platform and Naptumomab Estafenatox (NAP). NeoTX also facilitates clinical trial participation for patients with advanced solid tumors.","citation":{"profile_url":"https://www.vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd","record_status":"auto_indexed","index_status":"listed","vizoryo_profile_id":"vizoryo:profile:7e89f88e-d86b-4d4b-851c-b033e106cb8c","source_url":"https://neotx.com","name":"NeoTX","recommended_citation":"NeoTX — business identity (auto-indexed from public data; not confirmed by anyone) on Vizoryo, the Global AI Business Visibility Index. Source: https://www.vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd"},"confidence_computed_at":"2026-07-03T02:31:33.627+00:00","ai_providers":[],"confidence_sources":["Google Business Profile","AI Content Analysis","Website Scan"],"field_provenance":[{"field":"name","source_count":2,"confidence":1,"updated_at":"2026-07-03T02:31:33.627+00:00","confirmed_by":"cross_source"},{"field":"phone","source_count":1,"confidence":0.9,"updated_at":"2026-07-03T02:31:33.627+00:00","confirmed_by":"public_source"},{"field":"address","source_count":1,"confidence":0.9,"updated_at":"2026-07-03T02:31:33.627+00:00","confirmed_by":"public_source"},{"field":"category","source_count":1,"confidence":0.6,"updated_at":"2026-07-03T02:31:33.627+00:00","confirmed_by":"public_source"},{"field":"website","source_count":2,"confidence":1,"updated_at":"2026-07-03T02:31:33.627+00:00","confirmed_by":"cross_source"},{"field":"hours","source_count":1,"confidence":0.9,"updated_at":"2026-07-03T02:31:33.627+00:00","confirmed_by":"public_source"}],"recommendations":[{"check_id":"schema_depth","label":"AI Business Card Completeness","description":"Fill out your digital business card in your website code with your name, description, address, phone, hours, and photos — AI tools rely on these details to give accurate answers about your business, and missing fields mean missed recommendations.","tokens":{"businessName":"NeoTX","cmsHint":"","city":"Rehovot"},"priority":"high"},{"check_id":"review_quality","label":"Review Rating & Count","description":"Embed your Google star rating in your website code (using Schema.org AggregateRating) — a 4.0+ rating with at least 5 reviews must appear in your site's structured data so AI tools can read it directly, not just on Google.","tokens":{"businessName":"NeoTX","cmsHint":"","city":"Rehovot"},"priority":"high"},{"check_id":"google_review_volume","label":"Review Volume","description":"Build up enough reviews for your industry — AI tools weight businesses with more reviews far more often in recommendations. Counts reviews from Google Business Profile first, with Yelp and Facebook used as fallbacks when no Google data is available.","tokens":{"businessName":"NeoTX","cmsHint":"","city":"Rehovot"},"priority":"high"}]}}